{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:3316",
      "entity_text" : "HbA",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:10096344",
      "entity_text" : "linagliptin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "At week 12, adjusted mean HbA 1c decreased by -0.76% with linagliptin and -0.15% with placebo (treatment difference, -0.60%; 95% CI -0.89 to -0.31; P < 0.0001).",
  "reading_complete" : "2020-07-28T14:00:00Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T13:56:59Z",
  "trigger" : "decreased",
  "evidence" : [ "HbA 1c  decreased by -0.76% with linagliptin" ],
  "pmc_id" : "3554278",
  "score" : 0
}